Patents by Inventor Shlomit Wizel

Shlomit Wizel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070191331
    Abstract: The present invention encompasses the solid state chemistry of cefdinir potassium salt.
    Type: Application
    Filed: October 31, 2006
    Publication date: August 16, 2007
    Inventors: Vinod Kansal, Dhirenkumar Mistry, Saurabh Pandey, Rakesh Patel, Shlomit Wizel, Jean Hildesheim
  • Publication number: 20070185211
    Abstract: Provided are crystalline forms of cinacalcet HCl and processes for their preparation.
    Type: Application
    Filed: November 22, 2006
    Publication date: August 9, 2007
    Inventors: Shlomit Wizel, Revital Lifshitz-Liron, Sharon Avhar-Maydan
  • Patent number: 7250533
    Abstract: Processes for preparing cinacalcet are provided.
    Type: Grant
    Filed: May 16, 2006
    Date of Patent: July 31, 2007
    Assignee: Teva Pharmaceutical Industries Ltd
    Inventors: Revital Lifshitz-Liron, Amihai Eisenstadt, Shlomit Wizel, Sharon Avhar-Maydan, Yuriy Raizi, Revital Ramaty
  • Publication number: 20070123550
    Abstract: Provided is a crystalline rosuvastatin intermediate and processes for preparation thereof.
    Type: Application
    Filed: August 16, 2006
    Publication date: May 31, 2007
    Inventors: Valerie Niddam-Hildesheim, Natalia Shenkar, Shlomit Wizel
  • Publication number: 20070093458
    Abstract: The present invention is directed to a novel process for preparing Paricalcitol wherein Paricalcitol, dissolved in a solvent, is precipitated from a concentrated or seeded solution. The present invention also provides crystalline forms of paricalcitol and processes for their preparations.
    Type: Application
    Filed: September 12, 2006
    Publication date: April 26, 2007
    Inventors: Anchel Schwartz, Alexei Ploutno, Koby Wolfman, Shlomit Wizel
  • Publication number: 20070054963
    Abstract: Provided is amorphous cinacalcet hydrochloride, processes for the preparation thereof, and pharmaceutical compositions therewith.
    Type: Application
    Filed: May 23, 2006
    Publication date: March 8, 2007
    Inventors: Revital Lifshitz-Liron, Michael Pinchasov, Shlomit Wizel, Sharon Avhar-Maydan
  • Publication number: 20070043094
    Abstract: Provided is a novel crystal form of pioglitazone hydrochloride and a method for making it. Also provided is a method for making a known crystal form of pioglitazone hydrochloride.
    Type: Application
    Filed: October 27, 2006
    Publication date: February 22, 2007
    Inventors: Shlomit Wizel, Serguei Finogueev, Jean Hildesheim
  • Publication number: 20070043243
    Abstract: Processes for preparing cinacalcet are provided.
    Type: Application
    Filed: May 16, 2006
    Publication date: February 22, 2007
    Inventors: Revital Lifshitz-Liron, Amihai Eisenstadt, Shlomit Wizel, Sharon Avhar-Maydan, Yuriy Raizi, Revital Ramaty
  • Publication number: 20070043099
    Abstract: This invention relates to a novel crystalline form of carvedilol, to processes for its preparation, to compositions containing it and to its use in medicine. This invention further relates to a novel process for preparing crystalline carvedilol Form II.
    Type: Application
    Filed: June 9, 2006
    Publication date: February 22, 2007
    Inventors: Igor Lifshitz, Shlomit Wizel
  • Publication number: 20070004804
    Abstract: Provides are crystalline forms of nateglinide, labeled Forms A, C, D, F, G, I, J, K, L, M, N, 0, P, Q, T, U, V, Y, ?, ?, ?, ?, ?, ?, ?, 2 and ?, processes for their preparation and processes for preparation of other crystalline forms of nateglinide. Also provided are their pharmaceutical formulations and methods of administration.
    Type: Application
    Filed: September 5, 2006
    Publication date: January 4, 2007
    Inventors: Ronit Yahalomi, Evgeny Shapiro, Ben-Zion Dolitzky, Igal Gozlan, Boaz Gome, Shlomit Wizel
  • Publication number: 20060293377
    Abstract: Provided is the amorphous form of telmisartan sodium and the preparation thereof. Also provided are the telmisartan sodium polymorph crystal Forms 0 to XIII and XV to XX and preparations thereof. Also provided are pharmaceutical composition of amorphous and polymorphic forms of telmisartan sodium or mixtures thereof, and methods of treatment of a mammal in need thereof.
    Type: Application
    Filed: November 3, 2005
    Publication date: December 28, 2006
    Inventors: Shlomit Wizel, Nurit Perlman, Sharon Avhar-Maydan, Eyal Gilboa
  • Patent number: 7144916
    Abstract: The present invention provides novel forms of atorvastatin designated Forms VI, VIII, IX, X, XI and XII and novel processes for their preparation as well as processes for preparing atorvastatin Forms I, II, IV, V and amorphous atorvastatin.
    Type: Grant
    Filed: November 19, 2004
    Date of Patent: December 5, 2006
    Assignee: Teva Pharmaceutical Industries Ltd.
    Inventors: Judith Aronhime, Ramy Lidor-Hadas, Valerie Niddam, Revital Lifshitz, Shlomit Wizel
  • Publication number: 20060258676
    Abstract: Provided are novel crystalline forms of gatifloxacin, some of which are DMSO solvates, and methods for making them.
    Type: Application
    Filed: July 17, 2006
    Publication date: November 16, 2006
    Applicant: Teva Pharmaceutical Industries Ltd.
    Inventors: Ehud Amir, Valerie Niddam-Hildesheim, Greta Sterinbaum, Shlomit Wizel
  • Publication number: 20060258674
    Abstract: Provided are novel crystalline forms of gatifloxacin, some of which are DMSO solvates, and methods for making them.
    Type: Application
    Filed: July 17, 2006
    Publication date: November 16, 2006
    Applicant: Teva Pharmaceutical Industries Ltd.
    Inventors: Ehud Amir, Valerie Niddam-Hildesheim, Greta Sterinbaum, Shlomit Wizel
  • Publication number: 20060258675
    Abstract: Provided are novel crystalline forms of gatifloxacin, some of which are DMSO solvates, and methods for making them.
    Type: Application
    Filed: July 17, 2006
    Publication date: November 16, 2006
    Applicant: Teva Pharmaceutical Industries Ltd.
    Inventors: Ehud Amir, Valerie Niddam-Hildesheim, Greta Sterinbaum, Shlomit Wizel
  • Publication number: 20060258677
    Abstract: Provided are novel crystalline forms of gatifloxacin, some of which are DMSO solvates, and methods for making them.
    Type: Application
    Filed: July 17, 2006
    Publication date: November 16, 2006
    Applicant: Teva Pharmaceutical Industries Ltd.
    Inventors: Ehud Amir, Valerie Niddam-Hildesheim, Greta Sterimbaum, Shlomit Wizel
  • Patent number: 7135485
    Abstract: Provided is a novel crystal form of pioglitazone hydrochloride and a method for making it. Also provided is a method for making a known crystal form of pioglitazone hydrochloride.
    Type: Grant
    Filed: September 27, 2002
    Date of Patent: November 14, 2006
    Assignee: Teva Pharmaceutical Industries Ltd.
    Inventors: Shlomit Wizel, Serguei Finogueev, Jean Hildesheim
  • Publication number: 20060252771
    Abstract: Provided are novel crystalline forms of gatifloxacin, some of which are DMSO solvates, and methods for making them.
    Type: Application
    Filed: July 17, 2006
    Publication date: November 9, 2006
    Applicant: Teva Pharmaceutical Industries Ltd.
    Inventors: Ehud Amir, Valerie Niddam-Hildesheim, Greta Sterinbaum, Shlomit Wizel
  • Publication number: 20060252772
    Abstract: Provided are novel crystalline forms of gatifloxacin, some of which are DMSO solvates, and methods for making them.
    Type: Application
    Filed: July 17, 2006
    Publication date: November 9, 2006
    Applicant: Teva Pharmaceutical Industries Ltd.
    Inventors: Ehud Amir, Valerie Niddam-Hildesheim, Greta Sterimbaum, Shlomit Wizel
  • Publication number: 20060252770
    Abstract: Provided are novel crystalline forms of gatifloxacin, some of which are DMSO solvates, and methods for making them.
    Type: Application
    Filed: July 17, 2006
    Publication date: November 9, 2006
    Applicant: Tava Pharmaceutical Industries Ltd.
    Inventors: Ehud Amir, Valerie Niddam-Hildesheim, Greta Sterinbaum, Shlomit Wizel